Cited by 751Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Mackie, K.·2005·Handbook of Experimental Pharmacology

DOI 10.1007/3-540-26573-2_10

Open this paper in CoChat — free account

Abstract

CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.

Integrity signals

Registry

Crossref · 10.1007/3-540-26573-2_10

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citation
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citation
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085

Show all 103 references

Research works printed but not linked: 1

Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466

Sorted by citations

Items 501–600 of 751

Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats
Zubrzycki, M., Zubrzycka, M., Wysiadecki, G., Szemraj, J., Jerczyńska, H., & Stasiołek, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094665 · Cited by 6
Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
Xiao, J., Zhou, Y., Sun, L., & Wang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152167 · Cited by 6
Yoğun Bakım Ünitesinde Takip Edilen Sentetik Kannabinoid (Bonzai) Zehirlenmesi Olgularının Klinik Özellikleri
Altınışık, U., Altınışık, H. B., Şimşek, T., Doğu, T., Şimşek, E., & Aydın, H. (2015) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybdd.36025 · Cited by 6
The impact of cannabinoid receptor 1 absence on mouse liver mitochondria homeostasis: insight into mitochondrial unfolded protein response
Senese, R., Petito, G., Silvestri, E., Ventriglia, M., Mosca, N., Potenza, N., Russo, A., Falvo, S., Manfrevola, F., Cobellis, G., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1464773 · Cited by 5
Improvement in the Cognitive Function in Chronic Pain: Therapeutic Potential of the Endocannabinoid System
Karimi‐Haghighi, S., & Shaygan, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04814-8 · Cited by 5
Cannabinoid Modulation of Excitability and Short-Term Neuronal Dynamics in the Dorsal and Ventral Hippocampus
Tsotsokou, G., Sotiropoulou, I.-M., Stampolitis, K., Oikonomou, G. D., Avdi, A.-P., & Papatheodoropoulos, C. (2025) · Biology · doi:10.3390/biology14060642 · Cited by 5
The role of (E)-6-chloro-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-2-styrylquinazolin-4(3H)-one in the modulation of cannabinoidergic system. A pilot study
Plescia, F., Plescia, F., Raffa, D., Cavallaro, A., Lavanco, G., Maggio, B., Raimondi, M. V., Daidone, G., Brancato, A., & Cannizzaro, C. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.06.004 · Cited by 5
Lifetime cannabis use and childhood trauma increase risk of psychosis in carriers of CNR1 genetic variants: findings from the STREAM study
Loureiro, C. M., Zuelli, F. M. D. G. C., Fachim, H., Shuhama, R., de Oliveira, A. M., Menezes, P. R., Dalton, C., Louzada‐Júnior, P., Belangero, S. I., Coeli‐Lacchini, F. B., et al. (2023) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2882 · Cited by 5
Evaluation of [18F]RoSMA-18-d6 as a CB2 PET Radioligand in Nonhuman Primates
Haider, A., Wang, L., Gobbi, L. B., Li, Y., Chaudhary, A. F., Zhou, X. M., Chen, J., Zhao, C., Rong, J., Xiao, Z., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00222 · Cited by 5
Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes
Burdinski, D., Kodibagkar, A., Potter, K. W., Schuster, R. M., Evins, A. E., Ghosh, S., & Gilman, J. M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.34354 · Cited by 5
Fármacos cannabinoides para las enfermedades neurológicas: ¿qué hay detrás?
Fernández‐Ruíz, J. (2012) · Revista de Neurología · doi:10.33588/rn.5410.2011689 · Cited by 5
Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration
Piña‐Escudero, S. D., de Oliveira, M. O., Snyder, A., & Miller, B. L. (2021) · Neurocase · doi:10.1080/13554794.2021.1917620 · Cited by 5
Investigating endocannabinoid system and subjective responses to exercise in cancer patients: Rationale and future research directions
Gourshettiwar, A., Lacey, J., Kay, S., Stehn, J. R., Low, M., & Cheema, B. S. (2024) · JSAMS Plus · doi:10.1016/j.jsampl.2024.100073 · Cited by 5
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study
Kim, H. K., Zai, G. C., Müller, D. J., Husain, M. I., Lam, R. W. M., Frey, B. N., Soares, C. N., Parikh, S. V., Milev, R. V., Foster, J. A., et al. (2022) · Pharmacopsychiatry · doi:10.1055/a-1872-0844 · Cited by 5
CB1cannabinoid receptor antagonism for treating inflammation and arthritis
Lambert, D. M. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.8.1027 · Cited by 5
Coherent peptide-mediated activity in a neuronal network controlled by subcellular signaling pathway: Experiments and modeling
Zhang, X., Leng, G., & Feng, J. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.003 · Cited by 5
The Hyperpolarization-Activated Cation Current I h : The Missing Link Connecting Cannabinoids to Cognition
Vargish, G. A., & McBain, C. J. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.027 · Cited by 5
Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists
Thomas, B. F. (2009) · Drug Development Research · doi:10.1002/ddr.20333 · Cited by 5
Where Are We and Where Are We Going?
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0008 · Cited by 5
Endocannabinoid System
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_2 · Cited by 4
Alterations of the endocannabinoid system in autism spectrum disorder: a systematic review and meta-analysis
Jia, X., Gao, S., Liu, X., Feng, Z., Wang, X. X., Lan, K., Lu, Y., Han, L., Wei, Y. B., & Liu, J. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02031-x · Cited by 4
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
Blebea, N. M., Pușcașu, C., Hancu, G., Stăniguț, A. M., & Chiriță, C. (2025) · Pharmaceuticals · doi:10.3390/ph18060890 · Cited by 5
Evidence on the effect of in-utero cannabis exposure in neonates
Thayyil, B., & Yusuf, K. (2025) · Journal of Perinatology · doi:10.1038/s41372-025-02383-1 · Cited by 4
Bridging reward and resilience: the endocannabinoid system as a unifying mechanism in exercise-induced protection against major depressive disorder
Zhang, G., Hu, Q., & Zou, H. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1766980 · Cited by 4
Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology
Bailey, C. R., & Neumeister, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.011 · Cited by 4
Neural and Behavioral Correlates Associated with Adolescent Marijuana Use
Subramaniam, P., & Yurgelun-Todd, D. A. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00335-7 · Cited by 4
Chronic cannabis use affects cerebellum dependent visuomotor adaptation
Blithikioti, C., Miquel, L., Paniello-Castillo, B., Nuño, L., Gual, A., Ballester, B. R., Fernandez, A., Herreros, I., Verschure, P. F. M. J., & Balcells-Olivero, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.007 · Cited by 4
Clinical, Cognitive, and Neurobiological Correlates of Impaired Timing Abilities Associate to Cannabis Use: a Systematic Review
Escelsior, A., Trabucco, A., di Brozolo, M. R., Murri, M. B., da Silva, B. P., Serafini, G., & Amore, M. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01125-8 · Cited by 5
Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development
Scott, J. C. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.03.012 · Cited by 5
Laminar Distribution of Cannabinoid Receptor 1 in the Prefrontal Cortex of Nonhuman Primates
Han, Y., Dong, Q., Peng, J., Li, B.-M., Sun, C., & Ma, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03828-4 · Cited by 4
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
Sparkes, E., Timmerman, A., Markham, J. W., Boyd, R. A., Gordon, R., Walker, K. A., Kevin, R. C., Hibbs, D. E., Banister, S. D., Cairns, E. A., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00818 · Cited by 4
Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders
Kale, M. B., Umare, M. D., Wankhede, N. L., Deshmukh, R., Abbot, V., Anwer, M. K., Taksande, B. G., Upaganlawar, A. B., Umekar, M. J., Ramniwas, S., et al. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128318194240918113954 · Cited by 4
Acute and chronic cannabis vapor exposure influences basal and stress-induced release of glucocorticoids in male and female rats
Lightfoot, S. H. M., Baglot, S. L., Hume, C., Grace, L. M., McLaughlin, R. J., & Hill, M. N. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107263 · Cited by 4
Spinal dorsal horn neurons involved in the alleviating effects of cannabinoid receptor agonists on neuropathic allodynia-like behaviors in rats
Sueto, D., Eriko, I., Onishi, A., & Tsuda, M. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.02.008 · Cited by 4
Measurement of Inverse Agonism of the Cannabinoid Receptors
Fong, T. M. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381296-4.00008-7 · Cited by 4
Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
Gavryushov, S., Bashilov, A. A., Cherashev-Tumanov, K., Kuzmich, N. N., Burykina, T. I., & Izotov, B. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914874 · Cited by 4
Cannabis, Cannabinoide und das Endocannabinoidsystem
Schneider, M., Hoch, E., Simon, R., Pfeiffer-Gerschel, T., Kraus, L., Häuser, W., & Lutz, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_1 · Cited by 5
Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient
Andreias, L., Roffe, E., Eng, A. G., Yiu, K., Pashmforoosh, G., Khan, Z., Rahman, R., Kalantari, H., & Hassen, G. W. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.11.014 · Cited by 4
The link between cannabinoids and depression
Ebrahimi-Ghiri, M., & Khakpai, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00013-x · Cited by 4
Cardiac Transplantation and the Use of Cannabis
Shah, H., Fraser, M., Agdamag, A. C., Maharaj, V., Nzemenoh, B. N., Martin, C. M., Alexy, T., & Garry, D. J. (2021) · Life · doi:10.3390/life11101063 · Cited by 4
Innovative Clinical-Organizational Model to Ensure Appropriateness and Quality in the Management of Medical Cannabis: An Italian Regional Case
Russo, E., Cannas, C., Rivetti, M. S., Villa, C., & Rebesco, B. (2021) · Healthcare · doi:10.3390/healthcare9111425 · Cited by 4
Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
Kim, H. J. J., Zagzoog, A., Ceni, C., Ferrisi, R., Janz, N., & Laprairie, R. B. (2023) · Brain Sciences · doi:10.3390/brainsci13020314 · Cited by 4
Interactions of Cannabis and Amphetamine-Type Stimulants
Tambaro, S., & Bortolato, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_16 · Cited by 4
The Endocannabinoid System and the Neuroendocrine Control of Hydromineral Balance
Ruginsk, S. G., Vechiato, F. M. V., Elias, L. L. K., & Antunes‐Rodrigues, J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12158 · Cited by 4
EDITORIAL
Alexander, S., Mackie, K., & Ross, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00831.x · Cited by 4
Self-citation
Neuro-protection of swertisin against impairment induced by Aβ25-35 by acting on COX-2 to up-regulate 2-AG and suppressing neuroinflammation
Wu, J., Zhou, L., & Lang, C. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138429 · Cited by 3
The role of cannabinoids in the management of symptoms in palliative care patients
Graczyk, M., & Leppert, W. (2021) · Palliative Medicine in Practice · doi:10.5603/pmpi.2021.0016 · Cited by 3
The Relationship of glutamate signaling to cannabis use and schizophrenia
Niznikiewicz, M. A., Lin, A. P., & DeLisi, L. E. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001003 · Cited by 3
Effects of pharmacological inhibition of fatty acid amide hydrolase on corticosterone release: a systematic review of preclinical studies
Pereira, C. F., Boileau, I., & Kloiber, S. M. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00155-z · Cited by 3
The Effect of CB1r Hippocampal Activation on Behavioral Changes and BDNF Levels in Rapid‐Eye Movement Sleep‐Deprived Rats
Azizi, P., Najafi, A., Samizadeh, M., Mohamadian, M., Jabbari, A., Rezaie, M., & Vaseghi, S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70216 · Cited by 4
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
Cannabinoid CB1 receptor inverse agonist MJ08 stimulates glucose production via hepatic sympathetic innervation in rats
Chen, W., Liu, H., Guan, H., Xue, N., & Wang, L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.030 · Cited by 3
Cannabinoides y dolor PARTE I
Regueras, E., Torres, L. M., & Velázquez, I. (2023) · Multidisciplinary Pain Journal · doi:10.20986/mpj.2023.1052/2023 · Cited by 3
Altered Functional Connectivity Dynamics Serving Cognitive Flexibility in Regular Cannabis Users
McDonald, K. M., Schantell, M. D., John, J. A., Coutant, A. T., Glesinger, R. J., Horne, L. K., Okelberry, H. J., Springer, S. D., Embury, C. M., Arif, Y., et al. (2025) · Addiction Biology · doi:10.1111/adb.70023 · Cited by 3
CB-1 receptor agonist drastically changes oscillatory activity, defining active sleep
Topchiy, I., & Kocsis, B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411063122 · Cited by 5
The involvement of ventral hippocampal microglial cells, but not cannabinoid CB1 receptors, in morphine-induced analgesia in rats
Javid, H., Rezayof, A., Ghasemzadeh, Z., & Sardari, M. (2019) · Acta Neurologica Belgica · doi:10.1007/s13760-019-01144-0 · Cited by 3
Proposed mechanisms of cannabinoid hyperemesis syndrome—how can cannabinoid pathways both relieve and cause vomiting?
Sharkey, K. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00003-4 · Cited by 3
The role of transient receptor potential vanilloid 1 (TRPV1), a modulator of the endocannabinoid system in anxiety, depression, and cocaine addiction
Norzé, W., & Maldonado-Vlaar, C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00029-2 · Cited by 3
Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice
Rein, J. L., Mackie, K., Kleyman, T. R., & Satlin, L. M. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00320.2022 · Cited by 3
Self-citation
New Perspective in Pain Treatment
Rodella, L. F., Borsani, E., & Rezzani, R. (2010) · The Open Conference Proceedings Journal · doi:10.2174/22102892010010100061 · Cited by 3
Neuropsychiatric Complications of Substance Abuse
Ricaurte, G. A., Langston, J. W., & McCann, U. D. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50041-9 · Cited by 3
Synthetic Cannabinoids in Dementia
Amanullah, S. L., Shivakumar, K., Hassan, S., Canfield, A., & Cole, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00100-9 · Cited by 3
Cannabinoids and Synaptic Transmission in the Cerebellum
Myoga, M. H., & Regehr, W. G. (2012) · Springer eBooks · doi:10.1007/978-3-030-23810-0_39 · Cited by 3
Regulation of Synaptic Function by Endocannabinoids
Lovinger, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00028-0 · Cited by 3
Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues
Rodríguez, C. M. V., Meléndez, Y. E., & Flores‐Otero, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_4 · Cited by 3
Increased hippocampal cannabinoid 1 receptor expression is associated with protection from severe seizures in pregnant mice with reduced uterine perfusion pressure
Jones‐Muhammad, M., Pryor, T., Shao, Q., Freeman, K. B., & Warrington, J. P. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25244 · Cited by 2
Structure–Activity Relationship and Functional Evaluation of Cannabinoid Type-1 Receptor
Wang, S., Tian, X., Paudel, S., Ghil, S., Jang, C., & Kim, K. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.205 · Cited by 2
Natural language analysis of the structure of altered states of consciousness
Dikovskaya, D., Desikan, B. S., Frohlich, J., Hossain, N., Panariello, G., Johnson, L., & Murray, C. H. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00441 · Cited by 3
Anxiety, Depression, and Emotional Dysregulation Following Prenatal Substance Exposure
Diaz, M. R., Varlinskaya, E. I., & Schatz, K. C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12741-9_5 · Cited by 2
GPCRs as Targets for Plant-Derived Drugs
Böttger, A., Vothknecht, U. C., Bolle, C., & Wolf, A. (2018) · Learning materials in biosciences · doi:10.1007/978-3-319-99546-5_5 · Cited by 2
Neurodevelopmental outcomes following prenatal cannabidiol exposure in male and female Sprague Dawley rat offspring
Baccetto, S. L., Black, T., Barnard, I. L., Macfarlane, L. M., Sanfuego, G. B., Laprairie, R. B., & Howland, J. G. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.018 · Cited by 2
Subchronic Central Administration of Cannabinoid Ligands Modulates Nociception in Bulbectomized Rats
Tashev, R. E., Stavreva, G., & Velikova, M. (2019) · Folia Medica · doi:10.3897/folmed.61.e47957 · Cited by 2
Neurotoxic or Protective Cannabis Components: Delta-9-Tetrahydrocannabinol ( Δ9 THC) and Cannabidiol (CBD)
Silva, M. H. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00017 · Cited by 3
Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1
Petgrave, M., Ramgoolam, S. D., & Ganesan, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01579 · Cited by 2
A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory
Karimi‐Haghighi, S., Mozafari, R., Chavoshinezhad, S., Khosrowabadi, E., Mahmoudi, M., & Haghparast, A. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00588-6 · Cited by 2
Exploring β-caryophyllene: a non-psychotropic cannabinoid's potential in mitigating cognitive impairment induced by sleep deprivation
Lim, C. R., Ogawa, S., & Kumari, Y. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01523-z · Cited by 2
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease
de Souza, L. P., Sicoli, J., Saad, S. T. O., & Benites, B. D. (2025) · Expert Review of Hematology · doi:10.1080/17474086.2025.2471864 · Cited by 2
Edible cannabinoids impact meal structure and food impulsivity in female rats
Lord, M. N., Spaulding, M. O., Hoffman, J. R., Basma, R. K., & Noble, E. E. (2025) · iScience · doi:10.1016/j.isci.2025.112415 · Cited by 2
Stress reactivity is modulated by cannabinoid type-1 receptors in norepinephrine and epinephrine neurons in a context-dependent manner
Engborg, C. B., Pujar, M., Kanadia, R., & Sciolino, N. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.046 · Cited by 2
PROGRAMA DE PÓS-GRADUAÇÃO EM NEUROCIÊNCIAS
Saúde, B. D. (2010) · Cited by 2
Cannabinoids and the Neural Actions of Alcohol
Pava, M. J., & Lovinger, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00014-6 · Cited by 2
Endocannabinoids: the lipid effectors of metabolic regulation in health and disease
Jourdan, T., Degrace, P., González‐Mariscal, I., Szanda, G., & Tam, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00015-4 · Cited by 2
A critical narrative review of medical cannabis in pediatrics beyond epilepsy, part III: chemotherapy-induced nausea and vomiting and inflammatory bowel disease
Simonian, J. S., Varanasi, S., Richards, G. J., Nguyen, A. V., Diaz‐Fong, J. P., & Lê, J. (2020) · Pediatric Medicine · doi:10.21037/pm-20-70 · Cited by 2
The endocannabinoid system as a target for the treatment of neurological disorders
DeMesa, J., Appendino, G., Morello, G., Murray, M. P., & Muñóz, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00002-1 · Cited by 2
The Endocannabinoid System a Turning Point in Optimizing Physiotherapy Procedures in Knee Osteoarthritis
Onu, I., Buculei, I., Ionescu, C. G., Stanca, D. N., Voicu, B., & Iordan, D. A. (2023) · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE · doi:10.18662/brain/14.2/456 · Cited by 2
Endocannabinoid Signaling in the Habenula Regulates Adaptive Responses to Stress
Chen, Z., & Kenny, P. J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.08.001 · Cited by 2
The Pharmacology of Delta-9-Tetrahydrocannabinol (THC)
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0002 · Cited by 2
Endocannabinoid Signaling in the Striatum
Lovinger, D. M., & Mathur, B. N. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00010-6 · Cited by 5
Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma
Choucair, N., Saker, Z., Eddine, H. K., Bahmad, H. F., Fares, Y., Zaarour, M., Harati, H., & Nabha, S. M. (2022) · Pathologica · doi:10.32074/1591-951x-294 · Cited by 2
Endocannabinoid System in a Planarian Model
Mustonen, K. L. (2010) · doi:10.12794/metadc33188 · Cited by 2
Cannabinoids, endocannabinoids and stress
Hillard, C. J., Liu, Q., Liu, X., Pan, B., Roberts, C. J., & Shi, L. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch5 · Cited by 2
Retraction Note: Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors
Pietrzak, R. H., Huang, Y. H., Corsi-Travali, S., Zheng, M., Lin, S.-F., Henry, S. E., Potenza, M. N., Piomelli, D., Carson, R. E., & Neumeister, A. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00818-1 · Cited by 2
Retracted
Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research
Denson, R. K., Brooks, J. M., Pinna, G., & Crane, N. A. (2023) · Adolescent Psychiatry · doi:10.2174/0122106766233339230919143924 · Cited by 1
Network topology and cannabis use following two weeks of monitored abstinence: moderation of sex and patterns of use findings
Baacke, K. A., Sullivan, R. M., Shankula, C. A., & Lisdahl, K. M. (2025) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2025.1549771 · Cited by 2
Adolescent CB1 receptor expression at the BLA and CA1 and acute AM251 effects on sociability and emotional memory are sex-specific, and not modulated by heterotypic stress exposure
Person, E., & Plamondon, H. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115704 · Cited by 1
Cannabinol’s Modulation of Genes Involved in Oxidative Stress Response and Neuronal Plasticity: A Transcriptomic Analysis
Silvestro, S., Calabrò, M., Trainito, A., Salamone, S., Pollastro, F., Mazzon, E., & Minuti, A. (2025) · Antioxidants · doi:10.3390/antiox14060744 · Cited by 1
Cannabinoid‐Induced Hyperphagia is Mediated by Increased Meal Frequency and the Orexin‐1 Receptor in Male Rats
Lord, M. N., Madu, G. C., Loera‐Lopez, A. L., Aaron, A., Lin, J., & Noble, E. E. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70171 · Cited by 1
No differences in neural responses or performance during cannabis cue-specific inhibitory control tasks between recreational cannabis users and non-users: Insights from fNIRS
Pickering, C. R., Lorenzetti, V., Jones, A., Guest, M., Christiansen, P., & Roberts, C. A. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251358814 · Cited by 1
Adverse events associated with medical cannabis reported within a centralized call center
Illamola, S. M., Lyu, X., Luciana, M. M., Dahmer, S., Lehfeldt, P., Dikmen, S., Kaloustian, I., Garretson, M., Kingston, R. L., Leppik, I. E., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1792520 · Cited by 1
Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and Psychosis
Austin-Zimmerman, I., Li, Q., Johnson, E. C., Trotta, G., Spinazzola, E., Coleman, J. R. I., Li, Z., Bond, B. W., Quattrone, D., Levey, D. F., et al. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100711 · Cited by 1

Authors: Mackie, K.
Affiliations: University of Washington (US)
Corresponding author: Mackie, K.
ORCID: Mackie, K.
Venue: Handbook of Experimental Pharmacology
Publisher: Springer-Verlag
Published: 2005-12-23
Issue: 168
Pages: 299-325
DOI: 10.1007/3-540-26573-2_10
OpenAlex: W2149183149
Cited by: 744
References: 103
Citations by year: 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
FWCI: 26.30
Type: book chapter
Language: en
Open access: closed
Locations: Springer eBooks (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
MeSH terms: Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks